ABOS
Acumen Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $166.33M
- Employees
- 60
- Latest publication
- 2026-09-29
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 178,000USD | 0USD | 0USD |
| Cost Of Revenue | 46,000USD | 45,000USD | — | — | 45,000USD | 44,000USD | 45,000USD | 45,000USD |
| Gross Profit | -46,000USD | -45,000USD | — | — | -45,000USD | -44,000USD | -45,000USD | -45,000USD |
| Research Development | 16,484,000USD | 20,526,000USD | 21,968,000USD | 37,125,000USD | 25,266,000USD | 34,569,000USD | 27,247,000USD | 19,533,000USD |
| Selling General Administrative | 4,665,000USD | 4,673,000USD | 4,545,000USD | 4,625,000USD | 5,104,000USD | 5,028,000USD | 5,018,000USD | 4,848,000USD |
| Selling And Marketing Expenses | 46,000USD | — | — | — | — | — | — | 45,000USD |
| Total Operating Expenses | 21,103,000USD | 25,199,000USD | 26,513,000USD | 41,750,000USD | 30,370,000USD | 39,553,000USD | 32,265,000USD | 24,381,000USD |
| Operating Income | -21,149,000USD | -25,199,000USD | -26,513,000USD | -41,750,000USD | -30,370,000USD | -39,597,000USD | -32,265,000USD | -24,381,000USD |
| Interest Income | 1,064,000USD | 1,322,000USD | 1,639,000USD | 2,015,000USD | 2,471,000USD | 2,992,000USD | 3,504,000USD | 3,816,000USD |
| Interest Expense | 1,069,000USD | 1,087,000USD | 1,068,000USD | 1,046,000USD | 1,023,000USD | 1,037,000USD | 1,027,000USD | 1,004,000USD |
| Net Interest Income | -5,000USD | 235,000USD | 571,000USD | 969,000USD | 1,448,000USD | 1,955,000USD | 2,477,000USD | 2,812,000USD |
| Income Before Tax | -20,737,000USD | -25,138,000USD | -26,451,000USD | -40,950,000USD | -28,796,000USD | -37,154,000USD | -29,765,000USD | -20,537,000USD |
| Net Income | -20,737,000USD | -25,138,000USD | -26,451,000USD | -40,950,000USD | -28,796,000USD | -37,154,000USD | -29,765,000USD | -20,537,000USD |
| Net Income From Continuing Ops | -20,737,000USD | -25,138,000USD | -26,451,000USD | -40,950,000USD | -28,796,000USD | -37,154,000USD | -29,765,000USD | -20,537,000USD |
| Ebit | -21,149,000USD | -24,051,000USD | -25,383,000USD | -39,904,000USD | -27,773,000USD | -36,117,000USD | -28,738,000USD | -19,533,000USD |
| Ebitda | -21,103,000USD | -24,006,000USD | -25,336,000USD | -39,857,000USD | -27,728,000USD | -36,073,000USD | -28,693,000USD | -19,488,000USD |
| Depreciation And Amortization | 46,000USD | 45,000USD | 47,000USD | 47,000USD | 45,000USD | 44,000USD | 45,000USD | 45,000USD |
| Reconciled Depreciation | 46,000USD | 45,000USD | 47,000USD | 47,000USD | 45,000USD | 44,000USD | 45,000USD | 45,000USD |
| Total Other Income Expense Net | 412,000USD | 61,000USD | 62,000USD | 800,000USD | 1,574,000USD | 2,443,000USD | 2,500,000USD | 3,844,000USD |
| Income Tax Expense | — | — | — | — | — | 44,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 1,436,000USD | 1,436,000USD | 1,697,000USD |
| Cost Of Revenue | 184,000USD | 178,000USD | 42,318,000USD | 169,000USD | 12,305,000USD | 7,997,000USD | 8,576,000USD |
| Gross Profit | -184,000USD | -178,000USD | -42,318,000USD | -169,000USD | -12,305,000USD | -6,561,000USD | -6,879,000USD |
| Research Development | 104,885,000USD | 93,798,000USD | 42,318,000USD | 32,361,000USD | 12,305,000USD | 7,997,000USD | 8,576,000USD |
| Selling General Administrative | 18,947,000USD | 20,219,000USD | 18,820,000USD | 12,876,000USD | 7,279,000USD | 1,351,000USD | 926,000USD |
| Total Operating Expenses | 123,832,000USD | 114,017,000USD | 61,138,000USD | 45,237,000USD | 7,279,000USD | 1,351,000USD | 926,000USD |
| Operating Income | -123,832,000USD | -114,017,000USD | -61,138,000USD | -45,237,000USD | -19,584,000USD | -7,912,000USD | -7,805,000USD |
| Interest Income | 7,447,000USD | 14,317,000USD | 8,232,000USD | 2,392,000USD | 84,000USD | 1,000USD | 45,000USD |
| Interest Expense | 4,224,000USD | 4,068,000USD | 581,000USD | 2,381,000USD | 81,022,000USD | 0USD | 0USD |
| Net Interest Income | 3,223,000USD | 10,249,000USD | 8,232,000USD | 2,392,000USD | 84,000USD | 1,000USD | 45,000USD |
| Income Before Tax | -121,335,000USD | -102,329,000USD | -52,371,000USD | -42,856,000USD | -100,606,000USD | -7,325,000USD | -7,907,000USD |
| Net Income | -121,335,000USD | -102,329,000USD | -52,371,000USD | -42,856,000USD | -100,606,000USD | -7,325,000USD | -7,907,000USD |
| Net Income From Continuing Ops | -121,335,000USD | -102,329,000USD | -48,740,000USD | -42,856,000USD | -100,606,000USD | -7,325,000USD | -7,907,000USD |
| Ebit | -117,111,000USD | -98,261,000USD | -51,790,000USD | -42,856,000USD | -19,584,000USD | -7,325,000USD | -7,686,000USD |
| Ebitda | -116,927,000USD | -98,083,000USD | -51,606,000USD | -42,687,000USD | -19,580,000USD | -7,912,000USD | 119,000USD |
| Depreciation And Amortization | 184,000USD | 178,000USD | 184,000USD | 169,000USD | 4,000USD | 7,912,000USD | 7,805,000USD |
| Reconciled Depreciation | 184,000USD | 178,000USD | 194,000USD | 169,000USD | 4,000USD | 0USD | — |
| Total Other Income Expense Net | 2,497,000USD | 11,688,000USD | 8,767,000USD | 2,381,000USD | -81,022,000USD | 587,000USD | -102,000USD |
| Selling And Marketing Expenses | — | — | 184,000USD | — | — | — | — |
| Income Tax Expense | — | — | — | -2,381,000USD | 81,073,000USD | -1,000USD | -45,000USD |
| Non Operating Income Net Other | — | — | — | -11,000USD | -81,106,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -42,856,000USD | -100,606,000USD | -7,325,000USD | -7,686,000USD |
| Unclassified Operating Expenses | — | — | — | — | -12,305,000USD | -7,997,000USD | -8,576,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 116,007,000USD | 133,629,000USD | 122,833,000USD | 142,221,000USD | 171,897,000USD | 204,478,000USD | 238,992,000USD | 266,975,000USD |
| Cash And Equivalents | 59,443,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 110,197,000USD | 128,398,000USD | 116,865,000USD | 126,609,000USD | 143,369,000USD | 149,148,000USD | 171,557,000USD | 200,343,000USD |
| Short Term Investments | 50,754,000USD | 76,602,000USD | 62,876,000USD | 79,777,000USD | 106,559,000USD | 118,989,000USD | 135,930,000USD | 167,159,000USD |
| Total Current Assets | 115,513,000USD | 133,094,000USD | 122,252,000USD | 132,153,000USD | 148,404,000USD | 154,947,000USD | 178,306,000USD | 207,632,000USD |
| Other Current Assets | 5,316,000USD | 4,696,000USD | 4,762,000USD | 5,165,000USD | 4,720,000USD | 5,423,000USD | 6,590,000USD | 7,146,000USD |
| Other Non Current Assets | 263,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 58,744,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 46,848,000USD | 29,229,000USD | 30,007,000USD | 21,956,000USD | 24,861,000USD | 19,315,000USD | 27,607,000USD | 19,914,000USD |
| Other Current Liabilities | 7,533,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 57,263,000USD | 87,476,000USD | 70,430,000USD | 93,173,000USD | 117,077,000USD | 155,521,000USD | 181,816,000USD | 217,202,000USD |
| Total Equity Including Noncontrolling Interest | 57,263,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 152,000USD | 197,000USD | 243,000USD | 288,000USD | 335,000USD | 373,000USD | 339,000USD | 385,000USD |
| Accounts Payable | 13,379,000USD | 1,655,000USD | 554,000USD | 682,000USD | 2,103,000USD | 1,056,000USD | 5,648,000USD | 2,342,000USD |
| Common Stock | 7,000USD | 7,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -499,917,000USD | -467,199,000USD | -446,462,000USD | -421,324,000USD | -394,873,000USD | -353,923,000USD | -325,127,000USD | -287,973,000USD |
| Accumulated Other Comprehensive Income | -13,000USD | 21,000USD | 83,000USD | 109,000USD | 23,000USD | 15,000USD | -48,000USD | 518,000USD |
| Intangible Assets | — | 24,000USD | 29,000USD | 30,000USD | 50,000USD | 56,000USD | 75,000USD | — |
| Total Liab | — | 46,153,000USD | 52,403,000USD | 49,048,000USD | 54,820,000USD | 48,957,000USD | 57,176,000USD | 49,773,000USD |
| Other Current Liab | — | 13,451,000USD | 20,538,000USD | 17,530,000USD | 22,616,000USD | 18,121,000USD | 21,826,000USD | 17,443,000USD |
| Capital Stock | — | 7,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Cash | — | 51,796,000USD | 53,989,000USD | 46,832,000USD | 36,810,000USD | 30,159,000USD | 35,627,000USD | 33,184,000USD |
| Net Debt | — | -37,673,000USD | -22,678,000USD | -15,996,000USD | -6,709,000USD | -1,159,000USD | -5,925,000USD | -3,196,000USD |
| Short Term Debt | — | 14,123,000USD | 8,915,000USD | 3,744,000USD | 142,000USD | 138,000USD | 133,000USD | 129,000USD |
| Short Long Term Debt | — | 14,123,000USD | 8,765,000USD | 3,598,000USD | — | — | — | — |
| Short Long Term Debt Total | — | 14,123,000USD | 31,311,000USD | 30,836,000USD | 30,101,000USD | 29,000,000USD | 29,702,000USD | 29,988,000USD |
| Long Term Debt | — | 16,924,000USD | 22,396,000USD | 27,053,000USD | 29,882,000USD | 28,748,000USD | 28,449,000USD | 28,154,000USD |
| Property Plant Equipment Gross | — | 197,000USD | 243,000USD | 288,000USD | 335,000USD | 373,000USD | 339,000USD | 385,000USD |
| Common Stock Shares Outstanding | — | 63,219,289shares | 60,561,836shares | 60,573,425shares | 60,573,425shares | 60,525,628shares | 60,013,277shares | 60,079,778shares |
| Non Current Assets Total | — | 535,000USD | 581,000USD | 10,068,000USD | 23,493,000USD | 49,531,000USD | 60,686,000USD | 59,343,000USD |
| Non Current Liabilities Total | — | 16,924,000USD | 22,396,000USD | 27,092,000USD | 29,959,000USD | 29,642,000USD | 29,569,000USD | 29,859,000USD |
| Non Currrent Assets Other | — | 535,000USD | 350,000USD | 307,000USD | 311,000USD | 307,000USD | 379,000USD | 406,000USD |
| Net Working Capital | — | 103,865,000USD | 92,245,000USD | 110,197,000USD | 123,543,000USD | 135,632,000USD | 150,699,000USD | 187,718,000USD |
| Unclassified Current Liabilities | — | -14,123,000USD | -8,765,000USD | -3,598,000USD | — | — | — | — |
| Unclassified Equity | — | 554,640,000USD | 516,797,000USD | 514,376,000USD | 511,915,000USD | 509,417,000USD | 506,979,000USD | 504,645,000USD |
| Long Term Investments | — | — | 0USD | 9,443,000USD | 22,797,000USD | 48,795,000USD | 59,968,000USD | 58,552,000USD |
| Net Receivables | — | — | 625,000USD | 379,000USD | 315,000USD | 376,000USD | 398,000USD | 319,000USD |
| Inventory | — | — | — | — | — | — | 159,000USD | 143,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 1,120,000USD | 1,705,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 122,833,000USD | 238,992,000USD | 310,125,000USD | 196,587,000USD | 230,330,000USD | 44,429,000USD | 7,322,000USD |
| Intangible Assets | 29,000USD | 75,000USD | 169,000USD | — | — | — | — |
| Other Current Assets | 4,762,000USD | 6,590,000USD | 2,868,000USD | 2,525,000USD | 4,424,000USD | 543,000USD | 596,000USD |
| Total Liab | 52,403,000USD | 57,176,000USD | 43,152,000USD | 7,812,000USD | 5,147,000USD | 63,020,000USD | 18,742,000USD |
| Total Stockholder Equity | 70,430,000USD | 181,816,000USD | 266,973,000USD | 188,775,000USD | 225,183,000USD | -18,591,000USD | -11,420,000USD |
| Other Current Liab | 20,538,000USD | 21,826,000USD | 10,726,000USD | 6,067,000USD | 4,059,000USD | 5,836,000USD | 1,119,000USD |
| Common Stock | 6,000USD | 6,000USD | 6,000USD | 4,000USD | 4,000USD | — | — |
| Capital Stock | 6,000USD | 6,000USD | 6,000USD | 4,000USD | 4,000USD | 0USD | 0USD |
| Retained Earnings | -446,462,000USD | -325,127,000USD | -222,798,000USD | -170,427,000USD | -127,571,000USD | -26,965,000USD | -19,640,000USD |
| Cash | 53,989,000USD | 35,627,000USD | 66,886,000USD | 130,101,000USD | 122,162,000USD | 43,777,000USD | 6,552,000USD |
| Cash And Short Term Investments | 116,865,000USD | 171,557,000USD | 243,522,000USD | 177,605,000USD | 194,237,000USD | 43,777,000USD | 6,552,000USD |
| Total Current Assets | 122,252,000USD | 178,306,000USD | 246,615,000USD | 180,329,000USD | 198,661,000USD | 44,429,000USD | 7,178,000USD |
| Total Current Liabilities | 30,007,000USD | 27,607,000USD | 12,971,000USD | 7,812,000USD | 5,147,000USD | 6,367,000USD | 1,342,000USD |
| Net Debt | -22,678,000USD | -5,925,000USD | -38,399,000USD | -129,996,000USD | -122,162,000USD | -43,777,000USD | -6,552,000USD |
| Short Term Debt | 8,915,000USD | 133,000USD | 866,000USD | 105,000USD | 139,000USD | — | — |
| Short Long Term Debt | 8,765,000USD | — | — | — | — | — | — |
| Short Long Term Debt Total | 31,311,000USD | 29,702,000USD | 28,487,000USD | 105,000USD | 201,000USD | — | — |
| Long Term Debt | 22,396,000USD | 28,449,000USD | 27,337,000USD | — | — | — | — |
| Long Term Investments | 0USD | 59,968,000USD | 62,553,000USD | 15,837,000USD | 31,619,000USD | 0USD | — |
| Short Term Investments | 62,876,000USD | 135,930,000USD | 176,636,000USD | 47,504,000USD | 72,075,000USD | 0USD | — |
| Net Receivables | 625,000USD | 398,000USD | 225,000USD | -199USD | -83USD | 109,000USD | 30,000USD |
| Accounts Payable | 554,000USD | 5,648,000USD | 1,379,000USD | 1,640,000USD | 1,088,000USD | 531,000USD | 223,000USD |
| Property Plant Equipment Net | 243,000USD | 339,000USD | 503,000USD | 270,000USD | 36,000USD | 0USD | — |
| Property Plant Equipment Gross | 243,000USD | 339,000USD | 503,000USD | 270,000USD | 36,000USD | 0USD | — |
| Accumulated Other Comprehensive Income | 83,000USD | -48,000USD | 312,000USD | -751,000USD | -231,000USD | 0USD | — |
| Common Stock Shares Outstanding | 60,561,836shares | 60,013,277shares | 48,609,000shares | 40,601,936shares | 38,266,593shares | 28,651,796shares | 28,651,796shares |
| Non Current Assets Total | 581,000USD | 60,686,000USD | 63,510,000USD | 16,258,000USD | 31,669,000USD | 0USD | 144,000USD |
| Non Current Liabilities Total | 22,396,000USD | 29,569,000USD | 30,181,000USD | 1,745,000USD | 4,059,000USD | 56,653,000USD | 17,400,000USD |
| Non Currrent Assets Other | 581,000USD | 379,000USD | 285,000USD | 151,000USD | 14,000USD | — | 144,000USD |
| Net Working Capital | 92,245,000USD | 150,699,000USD | 233,644,000USD | 172,517,000USD | 193,514,000USD | 38,062,000USD | 5,836,000USD |
| Unclassified Current Liabilities | -8,765,000USD | — | — | — | — | — | — |
| Unclassified Equity | 516,797,000USD | 506,979,000USD | 489,447,000USD | 359,945,000USD | 352,977,000USD | 8,374,000USD | 8,220,000USD |
| Inventory | — | 159,000USD | 98,000USD | 199,000USD | 83USD | 91,000USD | 49,000USD |
| Unclassified Non Current Liabilities | — | 1,120,000USD | 2,844,000USD | 1,745,000USD | 4,059,000USD | 56,653,000USD | 17,400,000USD |
| Other Assets | — | — | 1USD | 0USD | 14,000USD | — | 144,000USD |
| Net Tangible Assets | — | — | — | 188,775,000USD | 225,183,000USD | -18,591,000USD | -11,420,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -20,737,000USD | -25,138,000USD | -26,451,000USD | -40,950,000USD | -28,796,000USD | -37,154,000USD | -29,765,000USD | -20,537,000USD |
| Depreciation | 46,000USD | 740,000USD | -260,000USD | 47,000USD | 45,000USD | 44,000USD | 45,000USD | 45,000USD |
| Stock Based Compensation | 2,396,000USD | 2,419,000USD | 2,461,000USD | 2,498,000USD | 2,474,000USD | 2,343,000USD | 2,338,000USD | 2,470,000USD |
| Other Non Cash Items | 2,301,000USD | -111,000USD | 2,988,000USD | 298,000USD | -482,000USD | -669,000USD | -948,000USD | -2,288,000USD |
| Change In Working Capital | -5,738,000USD | 2,994,000USD | -7,026,000USD | 6,275,000USD | -7,362,000USD | 8,221,000USD | 3,734,000USD | 3,765,000USD |
| Total Cash From Operating Activities | -24,128,000USD | -19,096,000USD | -30,489,000USD | -31,832,000USD | -34,121,000USD | -27,215,000USD | -24,596,000USD | -16,545,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -9,000USD | -79,000USD | 0USD | 0USD | -5,000USD |
| Free Cash Flow | -24,128,000USD | -19,096,000USD | -30,489,000USD | -31,841,000USD | -34,200,000USD | -27,215,000USD | -24,596,000USD | -16,550,000USD |
| Investments | -13,807,000USD | 26,250,000USD | 40,511,000USD | 38,483,000USD | 28,689,000USD | 29,663,000USD | -10,132,000USD | 37,699,000USD |
| Total Cashflows From Investing Activities | -13,807,000USD | 26,250,000USD | 40,511,000USD | 38,483,000USD | 28,689,000USD | 29,663,000USD | -10,132,000USD | 37,699,000USD |
| Total Cash From Financing Activities | 35,742,000USD | 2,000USD | 0USD | 0USD | -36,000USD | -9,000USD | -42,000USD | -128,000USD |
| Sale Purchase Of Stock | -149,000USD | 0USD | 0USD | 0USD | -73,000USD | -9,000USD | 0USD | 0USD |
| Issuance Of Capital Stock | 35,746,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | -2,193,000USD | 7,156,000USD | 10,022,000USD | 6,651,000USD | -5,468,000USD | 2,443,001USD | -34,771,001USD | 21,026,000USD |
| Begin Period Cash Flow | 53,989,000USD | 47,064,000USD | 36,810,000USD | 30,391,000USD | 35,859,000USD | 33,183,999USD | 67,955,000USD | 47,164,000USD |
| End Period Cash Flow | 51,796,000USD | 54,220,000USD | 46,832,000USD | 37,042,000USD | 30,391,000USD | 35,627,000USD | 33,183,999USD | 68,190,000USD |
| Other Cashflows From Financing Activities | 35,597,000USD | — | — | — | 37,000USD | 739,000USD | -42,000USD | -128,000USD |
| Unclassified Operating Cash Flow | -2,396,000USD | — | -2,201,000USD | — | — | — | — | — |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -121,335,000USD | -102,329,000USD | -52,371,000USD | -42,856,000USD | -100,606,000USD | -7,325,000USD | -7,907,000USD |
| Depreciation | -751,000USD | 178,000USD | 184,000USD | 169,000USD | 4,000USD | 4,000USD | 4,000USD |
| Stock Based Compensation | 9,852,000USD | 9,635,000USD | 6,145,000USD | 3,061,000USD | 922,000USD | 154,000USD | 174,000USD |
| Other Non Cash Items | 1,815,000USD | -5,352,000USD | -888,000USD | 487,000USD | 81,421,000USD | -586,000USD | 147,000USD |
| Change In Working Capital | -5,119,000USD | 11,653,000USD | 3,866,000USD | 3,986,000USD | 298,000USD | 307,000USD | 768,000USD |
| Total Cash From Operating Activities | -115,538,000USD | -86,215,000USD | -43,064,000USD | -35,153,000USD | -17,961,000USD | -7,450,000USD | -6,818,000USD |
| Capital Expenditures | -88,000USD | -16,000USD | -21,000USD | -161,000USD | -40,000USD | -40,000USD | -40,000USD |
| Free Cash Flow | -115,626,000USD | -86,231,000USD | -43,085,000USD | -35,314,000USD | -18,001,000USD | -7,450,000USD | -6,818,000USD |
| Investments | 134,021,000USD | 48,027,000USD | -143,284,000USD | 39,346,000USD | -104,080,000USD | -104,080,000USD | -104,080,000USD |
| Total Cashflows From Investing Activities | 133,933,000USD | 48,027,000USD | -171,671,000USD | 39,185,000USD | -104,120,000USD | -104,120,000USD | -104,120,000USD |
| Net Borrowings | 0USD | -739,000USD | 30,000,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | -34,000USD | 6,928,000USD | 151,753,000USD | 3,907,000USD | 200,466,000USD | 44,675,000USD | 6,239,000USD |
| Sale Purchase Of Stock | -73,000USD | -41,000USD | 0USD | 3,907,000USD | 170,435,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 7,938,000USD | 126,086,000USD | 3,792,000USD | 198,587,000USD | 44,675,000USD | 6,232,000USD |
| Change In Cash | 18,361,000USD | -31,260,000USD | -62,982,000USD | 7,939,000USD | 78,385,000USD | 37,225,000USD | -579,000USD |
| Begin Period Cash Flow | 35,859,000USD | 67,119,000USD | 130,101,000USD | 122,162,000USD | 43,777,000USD | 6,552,000USD | 7,131,000USD |
| End Period Cash Flow | 54,220,000USD | 35,859,000USD | 67,119,000USD | 130,101,000USD | 122,162,000USD | 43,777,000USD | 6,552,000USD |
| Dividends Paid | — | 0USD | 0USD | — | — | — | — |
| Other Cashflows From Financing Activities | — | -230,000USD | -151,000USD | 115,000USD | 31,910,000USD | 44,675,000USD | 6,239,000USD |
| Unclassified Financing Cash Flow | — | 7,938,000USD | 121,904,000USD | — | — | -44,675,000USD | -6,232,000USD |
| Other Cashflows From Investing Activities | — | — | 3,000USD | 39,346USD | -104,080USD | — | — |
| Unclassified Investing Cash Flow | — | — | -28,369,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | 2,560,000USD | 557,000USD | 308,000USD | 110,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 7,939,000USD | 78,385,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | -79,000USD | 200,000USD |
| Change To Inventory | — | — | — | — | — | 79,000USD | -200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.